These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 347892)

  • 21. Catecholamine levels in the brain of rats exposed by inhalation to benzalkonium chloride.
    Swiercz R; Grzelińska Z; Gralewicz S; Wasowicz W
    Int J Occup Med Environ Health; 2009; 22(2):107-13. PubMed ID: 19546095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antischizophrenic drugs.
    Hong JS; Yang HY; Fratta W; Costa E
    J Pharmacol Exp Ther; 1978 Apr; 205(1):141-7. PubMed ID: 24732
    [No Abstract]   [Full Text] [Related]  

  • 23. Stimulation of dopamine synthesis and release by morphine and D-ala2-D-leu5-enkephalin in the mouse striatum in vivo.
    Urwyler S; Tabakoff B
    Life Sci; 1981 May; 28(20):2277-86. PubMed ID: 6114377
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute effects of lithium on catecholamines, serotonin, and their major metabolites in discrete brain regions.
    Gottberg E; Grondin L; Reader TA
    J Neurosci Res; 1989 Mar; 22(3):338-45. PubMed ID: 2709448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. beta-Endorphin-induced increase in striatal dopamine turnover.
    van Loon GR; Kim C
    Life Sci; 1978 Sep; 23(9):961-70. PubMed ID: 703526
    [No Abstract]   [Full Text] [Related]  

  • 26. Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanisms.
    Jenner P; Clow A; Reavill C; Theodorou A; Marsden CD
    J Pharm Pharmacol; 1980 Jan; 32(1):39-44. PubMed ID: 6102125
    [No Abstract]   [Full Text] [Related]  

  • 27. Catecholamine alterations in basal ganglia after hippocampal lesions.
    Springer JE; Isaacson RL
    Brain Res; 1982 Dec; 252(1):185-8. PubMed ID: 7172020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain.
    Waldmeier PC; Maître L
    Psychopharmacology (Berl); 1977 Apr; 52(2):137-44. PubMed ID: 407597
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence for the role of brain norepinephrine and dopamine in "rebound" phenomenon seen during withdrawal after repeated exposure to benzodiazepines.
    Rastogi RB; Lapierre YD; Singhal RL
    J Psychiatr Res; 1977; 13(2):65-75. PubMed ID: 14257
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of disulfiram and chloral hydrate on the metabolism of catecholamines in rat liver and brain.
    Berger D; Weiner H
    Biochem Pharmacol; 1977 Apr; 26(8):741-7. PubMed ID: 856206
    [No Abstract]   [Full Text] [Related]  

  • 31. Increase by enkephalin of acetylcholine release from striatal slices of the rat.
    Hársing LG; Vizi ES; Knoll J
    Pol J Pharmacol Pharm; 1978; 30(2-3):387-95. PubMed ID: 209425
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of morphine on catecholamine metabolism during postnatal development.
    Roth BL; Galloway MP; Coscia CJ
    Brain Res; 1980 Sep; 197(2):561-4. PubMed ID: 7407575
    [No Abstract]   [Full Text] [Related]  

  • 33. Decrease of cyclic GMP in cerebellum by intrastriatal D-Ala2-met-enkephalinamide.
    Biggio G; Corda MG; Casu M; Gessa GL
    Life Sci; 1978 Jul; 23(4):335-9. PubMed ID: 211360
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of bromocriptine on locomotor activity and cerebral catecholamines in rodents.
    Dolphin AC; Jenner P; Sawaya MC; Marsden CD; Testa B
    J Pharm Pharmacol; 1977 Dec; 29(12):727-34. PubMed ID: 22618
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of dopamine in pilocarpine-induced catalepsy.
    Ahtee L; Kääriäinen I
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(1):25-38. PubMed ID: 4279348
    [No Abstract]   [Full Text] [Related]  

  • 36. Biochemical characterization of the dopaminergic innervation of the rat septum.
    Collu R; Stefanini E; Vernaleone F; Marchisio AM; Devoto P; Argiolas A
    Life Sci; 1980 May; 26(20):1665-73. PubMed ID: 7392803
    [No Abstract]   [Full Text] [Related]  

  • 37. Methionine enkephalin-induced shaking behavior in rats: dissociation from brain serotonin mechanisms.
    Drust EG; Sloviter RS; Conner JD
    Neuropharmacology; 1981 May; 20(5):473-5. PubMed ID: 7242868
    [No Abstract]   [Full Text] [Related]  

  • 38. Modulation of catecholamine metabolism in synaptosomes by a neuroregulatory factor from mammalian brain.
    Pastuszko A; Yee DK; Wilson DF
    Neurosci Lett; 1989 Mar; 98(1):111-7. PubMed ID: 2710394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral effects and in vivo degradation of intraventricularly administered dynorphin-(1-13) and D-Ala2-dynorphin-(1-11) in rats.
    Herman BH; Leslie F; Goldstein A
    Life Sci; 1980 Sep; 27(10):883-92. PubMed ID: 7191035
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects on striatal and mesolimbic dopamine systems of a new potential antipsychotic drug -mezilamine- with weak cataleptogenic properties.
    Uzan A; Le Fur G; Mitrani N; Kabouche M; Donadieu AM
    Life Sci; 1978 Jul; 23(3):261-73. PubMed ID: 29181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.